Leah Croll1, Charles A Szabo2, Noha Abou-Madi3, Orrin Devinsky1. 1. Neurology, NYU, New York City, New York. 2. Neurology, UTHSCSA, San Antonio, Texas. 3. Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York.
Abstract
OBJECTIVES: Nonhuman primates (NHPs) are model organisms for understanding the pathophysiology and treatment of epilepsy in humans, while data from human patients informs the diagnosis and treatment of NHP with seizures and epilepsy. We reviewed the literature and surveyed veterinarians at zoos and NHP research centers to (a) better define the range of seizures and epilepsy in NHP, (b) understand how NHPs can inform our knowledge of the pathophysiology and treatment of epilepsy in humans, and (c) identify gaps of knowledge and develop more effective guidelines to treat seizures and epilepsy in NHP. METHODS: We searched PrimateLit, PubMed, and Google Scholar for studies on experimental models of epilepsy in NHPs and on naturally occurring seizures and epilepsy in NHPs in captivity. In addition, we created a survey to assess methods to diagnose and treat epilepsy in NHPs. This survey was sent to 41 veterinarians at major international zoos and research facilities with NHP populations to study seizure phenomenology, diagnostic criteria for seizures and epilepsy, etiology, and antiseizure therapies in NHPs. RESULTS: We summarize the data from experimental and natural models of epilepsy in NHPs and case reports of epilepsy of unknown origin in captive primates. In addition, we present survey data collected from veterinarians at eight zoos and one research facility. Experimental data from NHP epilepsy models is abundant, whereas data from primates who develop epilepsy in the wild or in zoos is very limited, constraining our ability to advance evidence-based medicine. SIGNIFICANCE: Characterization of seizure or epilepsy models in NHPs will provide insights into mechanisms and new therapies that cannot be addressed by other animal models. NHP research will better inform species-specific diagnoses and outcomes. Wiley Periodicals, Inc.
OBJECTIVES: Nonhuman primates (NHPs) are model organisms for understanding the pathophysiology and treatment of epilepsy in humans, while data from humanpatients informs the diagnosis and treatment of NHP with seizures and epilepsy. We reviewed the literature and surveyed veterinarians at zoos and NHP research centers to (a) better define the range of seizures and epilepsy in NHP, (b) understand how NHPs can inform our knowledge of the pathophysiology and treatment of epilepsy in humans, and (c) identify gaps of knowledge and develop more effective guidelines to treat seizures and epilepsy in NHP. METHODS: We searched PrimateLit, PubMed, and Google Scholar for studies on experimental models of epilepsy in NHPs and on naturally occurring seizures and epilepsy in NHPs in captivity. In addition, we created a survey to assess methods to diagnose and treat epilepsy in NHPs. This survey was sent to 41 veterinarians at major international zoos and research facilities with NHP populations to study seizure phenomenology, diagnostic criteria for seizures and epilepsy, etiology, and antiseizure therapies in NHPs. RESULTS: We summarize the data from experimental and natural models of epilepsy in NHPs and case reports of epilepsy of unknown origin in captive primates. In addition, we present survey data collected from veterinarians at eight zoos and one research facility. Experimental data from NHP epilepsy models is abundant, whereas data from primates who develop epilepsy in the wild or in zoos is very limited, constraining our ability to advance evidence-based medicine. SIGNIFICANCE: Characterization of seizure or epilepsy models in NHPs will provide insights into mechanisms and new therapies that cannot be addressed by other animal models. NHP research will better inform species-specific diagnoses and outcomes. Wiley Periodicals, Inc.
Authors: P Perez-Mendes; M M Blanco; M E Calcagnotto; S M Cinini; J Bachiega; D Papoti; L Covolan; A Tannus; L E Mello Journal: Epilepsy Res Date: 2011-05-26 Impact factor: 3.045
Authors: C Akos Szabó; Koyle D Knape; M Michelle Leland; Jake Feldman; Karin J M McCoy; Gene B Hubbard; Jeff T Williams Journal: Epilepsia Date: 2009-04-06 Impact factor: 5.864
Authors: Jenessa L Gjeltema; Brigid Troan; Atis Muehlenbachs; Lindy Liu; Alexandre J Da Silva; Yvonne Qvarnstrom; Jeremy R Tobias; Michael R Loomis; Ryan S De Voe Journal: J Am Vet Med Assoc Date: 2016-02-01 Impact factor: 1.936
Authors: C Á Szabó; F S Salinas; A M Papanastassiou; J Begnaud; M Ravan; K S Eggleston; R Shade; C Lutz; M De La Garza Journal: Epilepsy Res Date: 2017-10-12 Impact factor: 3.045
Authors: C Akos Szabó; M Michelle Leland; László Sztonák; Santiago Restrepo; Richard Haines; Michael A Mahaney; Jeff T Williams Journal: Am J Primatol Date: 2004-02 Impact factor: 2.371
Authors: Vincent T Cunliffe; Richard A Baines; Carlo N G Giachello; Wei-Hsiang Lin; Alan Morgan; Markus Reuber; Claire Russell; Matthew C Walker; Robin S B Williams Journal: Seizure Date: 2014-10-13 Impact factor: 3.184
Authors: Bruce P Hermann; Aaron F Struck; Robyn M Busch; Anny Reyes; Erik Kaestner; Carrie R McDonald Journal: Nat Rev Neurol Date: 2021-09-22 Impact factor: 44.711
Authors: Mark Z Kos; Melanie A Carless; Lucy Blondell; M Michelle Leland; Koyle D Knape; Harald H H Göring; Charles Ákos Szabó Journal: Front Genet Date: 2021-08-20 Impact factor: 4.772